CPRX – Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc.CPRX
$21.62Name : Catalyst Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $2,578,682,368.00
EPSttm : 1.18
Catalyst Pharmaceuticals, Inc.
$21.62
1.95%$0.43Float Short %
4.94
Margin Of Safety %
47
Put/Call OI Ratio
0.19
EPS Next Q Diff
0.1
EPS Last/This Y
EPS This/Next Y
-0.1
Price
21.6
Target Price
32.22
Analyst Recom
1.11
Performance Q
3.84
Relative Volume
0.87
Beta
0.84
Ticker: CPRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | CPRX | 22.52 | 0.14 | 0.03 | 3068 |
| 2025-01-24 | CPRX | 22.63 | 0.13 | 1.04 | 3199 |
| 2025-01-27 | CPRX | 22.7 | 0.14 | 0.13 | 3231 |
| 2025-01-28 | CPRX | 22.86 | 0.14 | 0.01 | 3238 |
| 2025-01-29 | CPRX | 23.94 | 0.14 | 0.06 | 3264 |
| 2025-01-30 | CPRX | 23.19 | 0.12 | 0.02 | 3664 |
| 2025-01-31 | CPRX | 22.54 | 0.13 | 0.60 | 3579 |
| 2025-02-03 | CPRX | 22.62 | 0.18 | 0.09 | 4078 |
| 2025-02-04 | CPRX | 23.08 | 0.17 | 0.04 | 4206 |
| 2025-02-05 | CPRX | 23.4 | 0.17 | 0.07 | 4308 |
| 2025-02-06 | CPRX | 23.04 | 0.17 | 0.11 | 4312 |
| 2025-02-07 | CPRX | 22.88 | 0.17 | 0.08 | 4415 |
| 2025-02-10 | CPRX | 22.68 | 0.17 | 0.05 | 4437 |
| 2025-02-11 | CPRX | 22.56 | 0.17 | 0.72 | 4447 |
| 2025-02-12 | CPRX | 22.72 | 0.17 | 0.00 | 4475 |
| 2025-02-13 | CPRX | 23.25 | 0.17 | 0.30 | 4475 |
| 2025-02-14 | CPRX | 23.28 | 0.17 | 0.09 | 4497 |
| 2025-02-18 | CPRX | 22.93 | 0.17 | 0.16 | 4525 |
| 2025-02-19 | CPRX | 22.55 | 0.17 | 0.86 | 4543 |
| 2025-02-20 | CPRX | 22.06 | 0.18 | 0.60 | 4620 |
| 2025-02-21 | CPRX | 21.62 | 0.19 | 0.24 | 4667 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | CPRX | 22.51 | 88.1 | 120.1 | 2.04 |
| 2025-01-24 | CPRX | 22.55 | 88.1 | 126.4 | 2.04 |
| 2025-01-27 | CPRX | 22.71 | 88.1 | 128.3 | 2.04 |
| 2025-01-28 | CPRX | 22.83 | 88.1 | 127.8 | 2.04 |
| 2025-01-29 | CPRX | 23.95 | 88.1 | 143.2 | 2.04 |
| 2025-01-30 | CPRX | 23.19 | 88.1 | 114.4 | 2.04 |
| 2025-01-31 | CPRX | 22.53 | 88.1 | 115.6 | 2.04 |
| 2025-02-03 | CPRX | 22.62 | 88.1 | 126.7 | 2.04 |
| 2025-02-04 | CPRX | 23.09 | 88.1 | 133.2 | 2.04 |
| 2025-02-05 | CPRX | 23.37 | 88.1 | 130.1 | 2.04 |
| 2025-02-06 | CPRX | 23.06 | 88.1 | 120.6 | 2.04 |
| 2025-02-07 | CPRX | 22.90 | 88.1 | 123.3 | 2.04 |
| 2025-02-10 | CPRX | 22.76 | 88.1 | 123.6 | 2.04 |
| 2025-02-11 | CPRX | 22.58 | 88.1 | 122.9 | 2.04 |
| 2025-02-12 | CPRX | 22.72 | 88.1 | 128.0 | 2.04 |
| 2025-02-13 | CPRX | 23.22 | 88.1 | 134.0 | 2.04 |
| 2025-02-14 | CPRX | 23.27 | 88.1 | 126.0 | 2.04 |
| 2025-02-18 | CPRX | 22.91 | 88.1 | 120.3 | 2.04 |
| 2025-02-19 | CPRX | 22.53 | 88.1 | 119.5 | 2.04 |
| 2025-02-20 | CPRX | 22.06 | 88.1 | 118.3 | 2.04 |
| 2025-02-21 | CPRX | 21.60 | 88.1 | 118.4 | 2.04 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | CPRX | -8.16 | -1.66 | 6.33 |
| 2025-01-24 | CPRX | -8.16 | -1.66 | 6.33 |
| 2025-01-27 | CPRX | -8.16 | -1.62 | 6.33 |
| 2025-01-28 | CPRX | -8.16 | -1.62 | 6.29 |
| 2025-01-29 | CPRX | -8.16 | -1.62 | 6.29 |
| 2025-01-30 | CPRX | -8.16 | -1.62 | 6.29 |
| 2025-01-31 | CPRX | -8.16 | -1.62 | 6.29 |
| 2025-02-03 | CPRX | -8.16 | -1.13 | 6.29 |
| 2025-02-04 | CPRX | -8.16 | -1.13 | 6.29 |
| 2025-02-05 | CPRX | -8.16 | -1.13 | 6.29 |
| 2025-02-06 | CPRX | -8.16 | -1.13 | 6.29 |
| 2025-02-07 | CPRX | -8.16 | -1.13 | 6.29 |
| 2025-02-10 | CPRX | -8.16 | -1.31 | 6.31 |
| 2025-02-11 | CPRX | -7.99 | -1.31 | 6.31 |
| 2025-02-12 | CPRX | -7.99 | -1.31 | 5.10 |
| 2025-02-13 | CPRX | -7.99 | -1.31 | 5.10 |
| 2025-02-14 | CPRX | -7.31 | -1.31 | 5.08 |
| 2025-02-18 | CPRX | -7.31 | -1.08 | 4.94 |
| 2025-02-19 | CPRX | -9.22 | -1.08 | 4.94 |
| 2025-02-20 | CPRX | -9.22 | -1.08 | 4.94 |
| 2025-02-21 | CPRX | -9.22 | -1.08 | 4.94 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.35
Avg. EPS Est. Current Quarter
0.53
Avg. EPS Est. Next Quarter
0.45
Insider Transactions
-9.22
Institutional Transactions
-1.08
Beta
0.84
Average Sales Estimate Current Quarter
134
Average Sales Estimate Next Quarter
127
Fair Value
31.68
Quality Score
91
Growth Score
99
Sentiment Score
66
Actual DrawDown %
12.3
Max Drawdown 5-Year %
-49.9
Target Price
32.22
P/E
18.45
Forward P/E
15
PEG
0.45
P/S
5.6
P/B
3.9
P/Free Cash Flow
13.71
EPS
1.17
Average EPS Est. Cur. Y
2.04
EPS Next Y. (Est.)
1.94
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
31.01
Relative Volume
0.87
Return on Equity vs Sector %
2.4
Return on Equity vs Industry %
18
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.09
EBIT Estimation
118.4
Catalyst Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 167
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
stock quote shares CPRX – Catalyst Pharmaceuticals, Inc. Stock Price stock today
news today CPRX – Catalyst Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CPRX – Catalyst Pharmaceuticals, Inc. yahoo finance google finance
stock history CPRX – Catalyst Pharmaceuticals, Inc. invest stock market
stock prices CPRX premarket after hours
ticker CPRX fair value insiders trading